{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:50:50Z","timestamp":1765486250988,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:00Z","timestamp":1541980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3501-2","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T07:44:32Z","timestamp":1542008672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Mononeuritis multiplex: an uncommon neurological manifestation of cytomegalovirus reactivation in an HIV-infected patient"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3698-1037","authenticated-orcid":false,"given":"Pedro","family":"Palma","sequence":"first","affiliation":[]},{"given":"Andreia","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Duro","sequence":"additional","affiliation":[]},{"given":"N\u00e9lia","family":"Neves","sequence":"additional","affiliation":[]},{"given":"C\u00e2ndida","family":"Abreu","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Sarmento","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"key":"3501_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-1-4471-3834-1_7","volume-title":"Management, neuromuscular diseases: a Pratical approach to diagnosis and management","author":"M Swash","year":"1997","unstructured":"Swash M, Schwartz M. A clinical approach to the neuropathies. In: Swash M, Schwartz M, editors. Management, neuromuscular diseases: a Pratical approach to diagnosis and management. London: Springer-Verlag; 1997. p. 121\u201332."},{"key":"3501_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/COH.0000000000000103","volume":"9","author":"M Kaku","year":"2014","unstructured":"Kaku M, Simpson DM. HIV neuropathy. Curr Opin HIV AIDS. 2014;9:521\u20136.","journal-title":"Curr Opin HIV AIDS"},{"key":"3501_CR3","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.2165\/00003495-200059060-00005","volume":"59","author":"EA Wulff","year":"2000","unstructured":"Wulff EA, Wang AK, Simpson DM. HIV-associated peripheral neuropathy epidemiology, Pathophysiology and Treatment. Drugs. 2000;59:1251\u201360.","journal-title":"Drugs"},{"key":"3501_CR4","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/clinids\/14.2.608-a","volume":"14","author":"WL Drew","year":"1992","unstructured":"Drew WL. Cytomegalovirus infection in patients with AIDS. Clin Infect Dis. 1992;14:608\u201315.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"3501_CR5","first-page":"S37","volume":"10","author":"EF Bowen","year":"1996","unstructured":"Bowen EF, Griffiths PD, Davey CC, Emery VC, Johnson MA. Lessons from the natural history of cytomegalovirus. AIDS. 1996;10(Suppl 1):S37\u201341.","journal-title":"AIDS"},{"key":"3501_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/clinids\/20.4.747","volume":"20","author":"JA McCutchan","year":"1995","unstructured":"McCutchan JA. Cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis. 1995;20:747\u201354.","journal-title":"Clin Infect Dis"},{"key":"3501_CR7","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/mus.21465","volume":"40","author":"J Robinson-Papp","year":"2009","unstructured":"Robinson-Papp J, Simpson DM. Neuromuscular diseases associated with HIV-1 infection. Muscle Nerve. 2009;40:1043\u201353.","journal-title":"Muscle Nerve"},{"key":"3501_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2165\/00023210-200216050-00003","volume":"16","author":"M Maschke","year":"2002","unstructured":"Maschke M, Kastrup O, Diener H-C. CNS manifestations of cytomegalovirus infections: diagnosis and treatment. CNS Drugs. 2002;16:303\u201315.","journal-title":"CNS Drugs"},{"key":"3501_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.7326\/0003-4819-125-7-199610010-00008","volume":"125","author":"JR Arribas","year":"1996","unstructured":"Arribas JR, Storch GA, Clifford DB, Tselis AC. Cytomegalovirus encephalitis. Ann Intern Med. 1996;125:577\u201387.","journal-title":"Ann Intern Med"},{"key":"3501_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2006.03.005","volume":"37","author":"C Steininger","year":"2006","unstructured":"Steininger C, Puchhammer-St\u00f6ckl E, Popow-Kraupp T. Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART). J Clin Virol. 2006;37:1\u20139.","journal-title":"J Clin Virol"},{"key":"3501_CR11","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/cid\/civ687","volume":"61","author":"G Mirani","year":"2015","unstructured":"Mirani G, Williams PL, Chernoff M, Abzug MJ, Levin MJ, Seage GR, et al. Changing trends in complications and mortality rates among US youth and young adults with HIV infection in the era of combination antiretroviral therapy. Clin Infect Dis. 2015;61:1850\u201361.","journal-title":"Clin Infect Dis"},{"key":"3501_CR12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0733-8619(18)30204-4","volume":"10","author":"DM Simpson","year":"1992","unstructured":"Simpson DM, Olney RK. Peripheral neuropathies associated with human immunodeficiency virus infection. Neurol Clin. 1992;10:685\u2013711.","journal-title":"Neurol Clin"},{"key":"3501_CR13","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1128\/JCM.39.3.1148-1151.2001","volume":"39","author":"A Bestetti","year":"2001","unstructured":"Bestetti A, Pierotti C, Terreni M, Zappa A, Vago L, Lazzarin A, et al. Comparison of three nucleic acid amplification assays of cerebrospinal fluid for diagnosis of cytomegalovirus encephalitis. J Clin Microbiol. 2001;39:1148\u201351.","journal-title":"J Clin Microbiol"},{"key":"3501_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/00002030-199509030-00006","volume":"9","author":"J Gozlan","year":"1995","unstructured":"Gozlan J, el Amrani M, Baudrimont M, Costagliola D, Salord JM, Duvivier C, et al. A prospective evaluation of clinical criteria and polymerase chain reaction assay of cerebrospinal fluid for the diagnosis of cytomegalovirus-related neurological diseases during AIDS. AIDS. 1995;9:253\u201360.","journal-title":"AIDS"},{"key":"3501_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.2165\/00003495-199957050-00006","volume":"57","author":"EF Bowen","year":"1999","unstructured":"Bowen EF. Cytomegalovirus reactivation in patients infected with HIV: the use of polymerase chain reaction in prediction and management. Drugs. 1999;57:735\u201341.","journal-title":"Drugs"},{"key":"3501_CR16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2174\/187152611797636703","volume":"11","author":"SA Ross","year":"2011","unstructured":"Ross SA, Novak Z, Pati S, Boppana SB. Overview of the diagnosis of cytomegalovirus infection. Infect Disord Drug Targets. 2011;11:466\u201374.","journal-title":"Infect Disord Drug Targets"},{"key":"3501_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ana.410290205","volume":"29","author":"G Said","year":"1991","unstructured":"Said G, Lacroix C, Chemouilli P, Goulon-Goeau C, Roullet E, Penaud D, et al. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol. 1991;29:139\u201346.","journal-title":"Ann Neurol"},{"key":"3501_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.crad.2006.01.008","volume":"61","author":"CE Offiah","year":"2006","unstructured":"Offiah CE, Turnbull IW. The imaging appearances of intracranial CNS infections in adult HIV and AIDS patients. Clin Radiol. 2006;61:393\u2013401.","journal-title":"Clin Radiol"},{"key":"3501_CR19","first-page":"397","volume":"2","author":"DB Clifford","year":"1996","unstructured":"Clifford DB, Arribas JR, Storch GA, Tourtellote W, Wippold FJ. Magnetic resonance brain imaging lacks sensitivity for AIDS associated cytomegalovirus encephalitis. J Neuro-Oncol. 1996;2:397\u2013403.","journal-title":"J Neuro-Oncol"},{"key":"3501_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410420504","volume":"42","author":"JC McArthur","year":"1997","unstructured":"McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, et al. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol. 1997;42:689\u201398.","journal-title":"Ann Neurol"},{"key":"3501_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/01.qai.0000165799.59322.f5","volume":"39","author":"LA Cysique","year":"2005","unstructured":"Cysique LA, Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, et al. Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. J Acquir Immune Defic Syndr. 2005;39:426\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3501_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1086\/517379","volume":"177","author":"L Morris","year":"1998","unstructured":"Morris L, Silber E, Sonnenberg P, Eintracht S, Nyoka S, Lyons SF, et al. High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis. J Infect Dis. 1998;177:473\u20136.","journal-title":"J Infect Dis"},{"key":"3501_CR23","first-page":"120","volume":"4","author":"P Cinque","year":"1998","unstructured":"Cinque P, Cleator GM, Weber T, Monteyne P, Sindic C, Gerna G, et al. Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union concerted action on virus meningitis and encephalitis. J Neuro-Oncol. 1998;4:120\u201332.","journal-title":"J Neuro-Oncol"},{"key":"3501_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s002800050916","volume":"43","author":"BM Serabe","year":"1999","unstructured":"Serabe BM, Murry DJ, Dauser R, Nuchtern J, Durfee J, McGuffey L, et al. Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primates. Cancer Chemother Pharmacol. 1999;43:415\u20138.","journal-title":"Cancer Chemother Pharmacol"},{"key":"3501_CR25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s40506-014-0021-5","volume":"6","author":"BH Tan","year":"2014","unstructured":"Tan BH. Cytomegalovirus treatment. Curr Treat options Infect Dis. 2014;6:256\u201370.","journal-title":"Curr Treat options Infect Dis"},{"issue":"Suppl 2","key":"3501_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-1293.2011.00944_1.x","volume":"12","author":"M Nelson","year":"2011","unstructured":"Nelson M, Dockrell D, Edwards S, BHIVA Guidelines Subcommittee, Angus B, Barton S, et al. British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. HIV Med. 2011;12(Suppl 2):1\u2013140.","journal-title":"HIV Med."},{"key":"3501_CR27","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. Department of Health and Human Services. 2013. \n                    https:\/\/aidsinfo.nih.gov\/guidelines\/html\/4\/adult-and-adolescent-oi-prevention-and-treatment-guidelines\/318\/introduction\n                    \n                  . Accessed 20 Oct 2017."},{"key":"3501_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jns.2011.04.002","volume":"307","author":"AM Anderson","year":"2011","unstructured":"Anderson AM, Mosunjac MB, Corey AS, Fountain JA, Oshinski JN. Simultaneous typical and extraordinary imaging findings of AIDS-associated cytomegalovirus encephalitis. J Neurol Sci. 2011;307:174\u20137.","journal-title":"J Neurol Sci"},{"key":"3501_CR29","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/00006982-200507000-00015","volume":"25","author":"DE Goldberg","year":"2005","unstructured":"Goldberg DE, Smithen LM, Angelilli A, Freeman WR. HIV-associated retinopathy in the HAART era. Retina. 2005;25:633\u201349 quiz 682-3.","journal-title":"Retina"},{"key":"3501_CR30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/cid\/ciu291","volume":"59","author":"M Ruiz-Cruz","year":"2014","unstructured":"Ruiz-Cruz M, Alvarado-De La Barrera C, Ablanedo-Terrazas Y. Reyes-Ter\u00e1n G. Proposed clinical case definition for cytomegalovirus-immune recovery retinitis. Clin Infect Dis. 2014;59:298\u2013303.","journal-title":"Clin Infect Dis."},{"key":"3501_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1468-1293.2000.00012.x","volume":"1","author":"MA French","year":"2000","unstructured":"French MA, Lenzo N, John M, Mallal SA, McKinnon EJ, James IR, et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med. 2000;1:107\u201315.","journal-title":"HIV Med"},{"key":"3501_CR32","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1086\/650538","volume":"50","author":"A Canestri","year":"2010","unstructured":"Canestri A, Lescure F, Jaureguiberry S, Moulignier A, Amiel C, Marcelin AG, et al. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis. 2010;50:773\u20138.","journal-title":"Clin Infect Dis"},{"key":"3501_CR33","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1097\/QAD.0b013e328355e6b2","volume":"26","author":"MJ Peluso","year":"2012","unstructured":"Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A, et al. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS. 2012;26:1765\u201374.","journal-title":"AIDS"},{"key":"3501_CR34","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/cid\/ciu477","volume":"59","author":"SL Letendre","year":"2014","unstructured":"Letendre SL, Mills AM, Tashima KT, Thomas DA, Min SS, Chen S, et al. ING116070: a study of the pharmacokinetics and antiviral activity of Dolutegravir in cerebrospinal fluid in HIV-1-infected, Antiretroviral Therapy-Naive Subjects. Clin Infect Dis. 2014;59:1032\u20137.","journal-title":"Clin Infect Dis."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3501-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3501-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3501-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T19:05:16Z","timestamp":1573499116000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3501-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3501"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3501-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2018,11,12]]},"assertion":[{"value":"21 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of data and images contained in this case report. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"554"}}